These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9193210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia.
    Trouillas P, Xie J, Adeleine P.
    Prog Brain Res; 1997; 114():589-99. PubMed ID: 9193169
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of buspirone for treatment of cerebellar ataxia. An open-label study.
    Lou JS, Goldfarb L, McShane L, Gatev P, Hallett M.
    Arch Neurol; 1995 Oct; 52(10):982-8. PubMed ID: 7575226
    [Abstract] [Full Text] [Related]

  • 5. [Buspirone chlorhydrate in the treatment of cerebellar ataxia].
    Andrade-Filho AS, Passos-Almeida J, Andrade-Souza VM, Sena-Pereira LR.
    Rev Neurol; 1995 Oct; 35(4):301-5. PubMed ID: 12235556
    [Abstract] [Full Text] [Related]

  • 6. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P, Xie J, Adeleine P.
    Lancet; 1996 Sep 14; 348(9029):759. PubMed ID: 8806320
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Buspirone in the treatment of cerebellar ataxia].
    Svetel M, Vojvodić N, Filipović SR, Dragasević N, Sternić N, Kostić VS.
    Srp Arh Celok Lek; 1999 Sep 14; 127(9-10):312-5. PubMed ID: 10649900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized double-blind placebo-controlled crossover-style trial of buspirone in functional dysphagia and ineffective esophageal motility.
    Aggarwal N, Thota PN, Lopez R, Gabbard S.
    Neurogastroenterol Motil; 2018 Feb 14; 30(2):. PubMed ID: 28884884
    [Abstract] [Full Text] [Related]

  • 14. Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy.
    Gazulla J, Benavente I.
    Acta Neurol Scand; 2007 Oct 14; 116(4):235-8. PubMed ID: 17824901
    [Abstract] [Full Text] [Related]

  • 15. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
    Landén M, Eriksson O, Sundblad C, Andersch B, Naessén T, Eriksson E.
    Psychopharmacology (Berl); 2001 May 14; 155(3):292-8. PubMed ID: 11432692
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST, Park JH, Kim M.
    Headache; 2005 Sep 14; 45(8):1004-11. PubMed ID: 16109114
    [Abstract] [Full Text] [Related]

  • 18. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
    McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J.
    Drug Alcohol Depend; 2015 Nov 01; 156():29-37. PubMed ID: 26386827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.